UniProt ID | IDH3B_HUMAN | |
---|---|---|
UniProt AC | O43837 | |
Protein Name | Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial | |
Gene Name | IDH3B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 385 | |
Subcellular Localization | Mitochondrion. | |
Protein Description | Plays a structural role to facilitate the assembly and ensure the full activity of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers.. | |
Protein Sequence | MAALSGVRWLTRALVSAGNPGAWRGLSTSAAAHAASRSQAEDVRVEGSFPVTMLPGDGVGPELMHAVKEVFKAAAVPVEFQEHHLSEVQNMASEEKLEQVLSSMKENKVAIIGKIHTPMEYKGELASYDMRLRRKLDLFANVVHVKSLPGYMTRHNNLDLVIIREQTEGEYSSLEHESARGVIECLKIVTRAKSQRIAKFAFDYATKKGRGKVTAVHKANIMKLGDGLFLQCCEEVAELYPKIKFETMIIDNCCMQLVQNPYQFDVLVMPNLYGNIIDNLAAGLVGGAGVVPGESYSAEYAVFETGARHPFAQAVGRNIANPTAMLLSASNMLRHLNLEYHSSMIADAVKKVIKVGKVRTRDMGGYSTTTDFIKSVIGHLQTKGS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAALSGVRWLTR ---CCHHHHHHHHHH | 30.43 | 24719451 | |
11 | Phosphorylation | LSGVRWLTRALVSAG HHHHHHHHHHHHHCC | 13.61 | 24719451 | |
29 | Phosphorylation | AWRGLSTSAAAHAAS HHHCCCHHHHHHHHH | 16.72 | 25599653 | |
36 | Phosphorylation | SAAAHAASRSQAEDV HHHHHHHHHHHCCCC | 32.99 | 25599653 | |
47 | Ubiquitination | AEDVRVEGSFPVTML CCCCEEECEECCEEC | 31.56 | 21890473 | |
47 (in isoform 3) | Acetylation | - | 31.56 | - | |
68 | Acetylation | PELMHAVKEVFKAAA HHHHHHHHHHHHHCC | 49.28 | 25038526 | |
96 (in isoform 2) | Acetylation | - | 53.96 | - | |
96 | Ubiquitination | QNMASEEKLEQVLSS HHHCCHHHHHHHHHH | 53.96 | 19608861 | |
96 | Acetylation | QNMASEEKLEQVLSS HHHCCHHHHHHHHHH | 53.96 | 23954790 | |
102 | Phosphorylation | EKLEQVLSSMKENKV HHHHHHHHHHHHCCE | 29.54 | 22210691 | |
103 | Phosphorylation | KLEQVLSSMKENKVA HHHHHHHHHHHCCEE | 29.70 | 22210691 | |
105 | Succinylation | EQVLSSMKENKVAII HHHHHHHHHCCEEEE | 61.15 | 27452117 | |
105 | Acetylation | EQVLSSMKENKVAII HHHHHHHHHCCEEEE | 61.15 | 25038526 | |
105 (in isoform 2) | Ubiquitination | - | 61.15 | 21890473 | |
105 | Ubiquitination | EQVLSSMKENKVAII HHHHHHHHHCCEEEE | 61.15 | - | |
113 (in isoform 1) | Ubiquitination | - | 19.42 | 21890473 | |
114 | Acetylation | NKVAIIGKIHTPMEY CCEEEEEEECCCCHH | 22.39 | 25953088 | |
117 | Phosphorylation | AIIGKIHTPMEYKGE EEEEEECCCCHHCCC | 28.01 | 24719451 | |
121 | Phosphorylation | KIHTPMEYKGELASY EECCCCHHCCCHHCH | 20.31 | 24719451 | |
122 | Acetylation | IHTPMEYKGELASYD ECCCCHHCCCHHCHH | 32.38 | 25953088 | |
135 | Malonylation | YDMRLRRKLDLFANV HHHHHHHHHHHHCCE | 39.66 | 26320211 | |
135 | Ubiquitination | YDMRLRRKLDLFANV HHHHHHHHHHHHCCE | 39.66 | - | |
135 | Acetylation | YDMRLRRKLDLFANV HHHHHHHHHHHHCCE | 39.66 | 25953088 | |
146 (in isoform 2) | Acetylation | - | 31.25 | - | |
146 | Acetylation | FANVVHVKSLPGYMT HCCEEEHHHCCCCHH | 31.25 | 23236377 | |
147 | Phosphorylation | ANVVHVKSLPGYMTR CCEEEHHHCCCCHHC | 38.41 | 27135362 | |
167 | Phosphorylation | LVIIREQTEGEYSSL EEEEEECCCCCCCCC | 41.00 | 21406692 | |
171 | Phosphorylation | REQTEGEYSSLEHES EECCCCCCCCCCHHH | 17.89 | 21406692 | |
172 | Phosphorylation | EQTEGEYSSLEHESA ECCCCCCCCCCHHHH | 24.93 | 21406692 | |
173 | Phosphorylation | QTEGEYSSLEHESAR CCCCCCCCCCHHHHH | 36.55 | 21406692 | |
178 | Phosphorylation | YSSLEHESARGVIEC CCCCCHHHHHHHHHH | 25.77 | 21406692 | |
199 | Acetylation | AKSQRIAKFAFDYAT HHHHHHHHHHHHHHC | 34.55 | 19608861 | |
199 | Ubiquitination | AKSQRIAKFAFDYAT HHHHHHHHHHHHHHC | 34.55 | 21890473 | |
199 (in isoform 2) | Ubiquitination | - | 34.55 | 21890473 | |
199 (in isoform 2) | Acetylation | - | 34.55 | - | |
207 | Succinylation | FAFDYATKKGRGKVT HHHHHHCCCCCCCEE | 45.09 | 23954790 | |
207 (in isoform 1) | Ubiquitination | - | 45.09 | 21890473 | |
207 | Ubiquitination | FAFDYATKKGRGKVT HHHHHHCCCCCCCEE | 45.09 | - | |
207 | Acetylation | FAFDYATKKGRGKVT HHHHHHCCCCCCCEE | 45.09 | 23236377 | |
212 | Ubiquitination | ATKKGRGKVTAVHKA HCCCCCCCEEEEEEC | 34.74 | - | |
218 | Ubiquitination | GKVTAVHKANIMKLG CCEEEEEECCCEECC | 36.21 | - | |
218 | Acetylation | GKVTAVHKANIMKLG CCEEEEEECCCEECC | 36.21 | 25825284 | |
222 (in isoform 3) | Acetylation | - | 2.69 | - | |
242 | Ubiquitination | EVAELYPKIKFETMI HHHHHCCCCCCEEEE | 45.00 | - | |
242 | Acetylation | EVAELYPKIKFETMI HHHHHCCCCCCEEEE | 45.00 | 25953088 | |
323 | Phosphorylation | GRNIANPTAMLLSAS CCCCCCHHHHHHHHH | 25.22 | 20068231 | |
330 | Phosphorylation | TAMLLSASNMLRHLN HHHHHHHHHHHHHCC | 21.28 | - | |
350 | Acetylation | SMIADAVKKVIKVGK HHHHHHHHHHHHCCC | 42.94 | 25953088 | |
360 (in isoform 2) | Phosphorylation | - | 33.73 | - | |
363 | Sulfoxidation | GKVRTRDMGGYSTTT CCEECCCCCCCCCHH | 3.96 | 28183972 | |
366 | Phosphorylation | RTRDMGGYSTTTDFI ECCCCCCCCCHHHHH | 9.34 | 22817900 | |
367 | Phosphorylation | TRDMGGYSTTTDFIK CCCCCCCCCHHHHHH | 23.66 | 24043423 | |
368 | Phosphorylation | RDMGGYSTTTDFIKS CCCCCCCCHHHHHHH | 25.82 | 24043423 | |
369 | Phosphorylation | DMGGYSTTTDFIKSV CCCCCCCHHHHHHHH | 20.59 | 24043423 | |
370 | Phosphorylation | MGGYSTTTDFIKSVI CCCCCCHHHHHHHHH | 29.06 | 24043423 | |
374 | Acetylation | STTTDFIKSVIGHLQ CCHHHHHHHHHHHHH | 38.37 | 23954790 | |
375 | Phosphorylation | TTTDFIKSVIGHLQT CHHHHHHHHHHHHHC | 17.72 | - | |
383 | Ubiquitination | VIGHLQTKGS----- HHHHHHCCCC----- | 44.17 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IDH3B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IDH3B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IDH3B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
IDH3G_HUMAN | IDH3G | physical | 26186194 | |
ODB2_HUMAN | DBT | physical | 26186194 | |
CASP3_HUMAN | CASP3 | physical | 26344197 | |
IDHC_HUMAN | IDH1 | physical | 26344197 | |
IDH3G_HUMAN | IDH3G | physical | 28514442 | |
ODB2_HUMAN | DBT | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
612572 | Retinitis pigmentosa 46 (RP46) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-146; LYS-199 AND LYS-374,AND MASS SPECTROMETRY. |